-
Kizdar net |
Kizdar net |
Кыздар Нет
Targeted and immunotherapeutic strategies for castration ... - Frontiers
Oct 22, 2025 · In recent years, the breakthrough of new drugs in targeted therapy and immunotherapy, as well as the emergence of …
Three new drugs for metastatic prostate cancer approved by FDA
Feb 13, 2026 · FDA approves new options that may allow some men with advanced prostate cancer to delay or avoid chemotherapy. …
Induced proximity-based therapeutics for advanced prostate cancer
Aug 14, 2026 · Metastatic castration-resistant prostate cancers (mCRPC) remain dependent on androgen receptor (AR) signaling …
Metastatic castration-resistant prostate cancer (mCRPC)
Dec 24, 2025 · For metastatic castration-resistant prostate cancer, targeted therapy medicines might be used when hormone therapy …
Targeted Therapy Drug List by Cancer Type - NCI
May 14, 2025 · Targeted therapy is a type of cancer treatment that targets the changes in cancer cells that help them grow, divide, …
Emerging Therapeutic Targets in Castration-Resistant Prostate …
Apr 1, 2026 · In this review, we discuss current knowledge of resistance mechanisms, therapeutic targets, and the potential role of …
The Contemporary Treatment Landscape of mCRPC - Urology Times
Feb 27, 2025 · Can you briefly discuss the contemporary treatment landscape of mCRPC? What are the unmet needs for the …
Evolving Treatment Landscape in Metastatic Castration-Resistant ...
An expert discusses how combining androgen receptor pathway inhibitors (ARPIs) with PARP inhibitors, particularly enzalutamide …
Advances in mCRPC Management: Recent Approvals, Emerging Therapies…
Nov 15, 2024 · There is an urgent unmet need for novel and targeted therapies for mCRPC, particularly for patients who have …
ESMO 2025: Optimized Use of Immunotherapy and Targeted Therapies in mCRPC
(UroToday.com) The 2025 ESMO annual meeting featured a metastatic castration-resistant prostate cancer (mCRPC) session and a …
Skip to content
Accessibility Feedback